Evidence map›Paper›PMID 22909205›Full record

ReviewPharmacogenomics2012

Epigenetics of drug abuse: predisposition or response.

David A Nielsen, Amol Utrankar, Jennifer A Reyes, Daniel D Simons, Thomas R Kosten

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacogenomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. EpiBrain: the brain's epigenetic landscape in a snapshot.bioRxiv : the preprint server for biology · 2026
    Article
  3. Decoding the role of mNeurochemistry international · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Opioid system and related ligands: from the past to future perspectives.Journal of anesthesia, analgesia and critical care · 2024
    Review
  10. Review
  11. Review
  12. Nicotine on the developing brain.Pharmacological research · 2023
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Differences inFrontiers in genetics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

David A NielsenMenninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine & the Michael E DeBakey VA Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA. nielsen@bcm.edu
Amol Utrankar
Jennifer A Reyes
Daniel D Simons
Thomas R Kosten
Rice University · USBaylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

Tiagabine and Disulfiram for Cocaine DependenceP50DA018197 · NIDA · YALE UNIVERSITY · PI KOSTEN, THOMAS RICHARD · 2004 to 2013
$12.6M
NIDA NIH HHS 5P50 DA018197-05NIDA NIH HHS P50 DA018197
6 · The paper itself

Abstract

Drug addiction continues to be a serious medical and social problem. Vulnerability to develop an addiction to drugs is dependent on genetic, environmental, social and biological factors. In particular, the interactions of environmental and genetic factors indicate the significance of epigenetic mechanisms, which have been found to occur in response to illicit drug use or as underlying factors in chronic substance abuse and relapse. Epigenetics is defined as the heritable and possibly reversible modifications in gene expression that do not involve alterations in the DNA sequence. This review discusses the various types of epigenetic modifications and their relevance to drug addiction to elucidate whether epigenetics is a predisposing factor, or a response to, developing an addiction to drugs of abuse.

Indexed as

Epigenesis, GeneticBehavior, AddictiveChromatin Assembly and DisassemblyCocaineDNA MethylationGenetic Predisposition to DiseaseHeroinHumansReceptors, Opioid, muSerotonin Plasma Membrane Transport ProteinsSubstance-Related DisordersCocaineHeroinOPRM1 protein, humanReceptors, Opioid, muSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID22909205
PMCPMC3463407
OpenAlexW2023044136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.